Drug:
Reaction: NASOPHARYNGITIS
20260101 - 20261231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 26875586 |
AR |
54 | 2 |
Hypothermia, Pyrexia, Headache, Nasopharyngitis, Tremor, Body temperature abnormal, Musculoskeletal stiffness, Pain in extremity, Influenza, Pain, Ill-defined disorder, |
||||
OFATUMUMAB, |
||||
| 402 | 26875654 |
US |
66 | 1 |
Influenza, Nasopharyngitis, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 403 | 26875831 |
US |
2 | |
Nasopharyngitis, |
||||
TILDRAKIZUMAB-ASMN, |
||||
| 404 | 26875927 |
US |
||
Nasopharyngitis, Viral infection, Decreased appetite, Weight decreased, Intentional product misuse, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 405 | 26873380 |
US |
57 | 1 |
Respiratory disorder, Body temperature abnormal, Nasopharyngitis, Viral infection, |
||||
ELIGLUSTAT, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, EPINEPHRINE, ADRENALINUM, FEXOFENADINE HYDROCHLORIDE, MORPHINE SULFATE, TOPIRAMATE, CROMOLYN SODIUM, BUPROPION HYDROCHLORIDE, ERGOCALCIFEROL, IRON, ZOLPIDEM TARTRATE, CHLORHEXIDINE GLUCONATE, MONTELUKAST SODIUM, MONTELUKAST, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MORPHINE SULFATE, |
||||
| 406 | 26873401 |
US |
2 | |
Cough, Asthma, Nasopharyngitis, Sinusitis, |
||||
DUPILUMAB, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 407 | 26873476 |
US |
1 | |
Nasopharyngitis, Off label use, Diarrhoea, |
||||
FOSTAMATINIB, |
||||
| 408 | 26873621 |
US |
2 | |
Nasopharyngitis, Cough, Diarrhoea, |
||||
FOSTAMATINIB, |
||||
| 409 | 26873763 |
US |
2 | |
Muscle spasms, Nasopharyngitis, Tendonitis, Off label use, Product dose omission issue, Diarrhoea, |
||||
FOSTAMATINIB, FOSTAMATINIB, BENZONATATE, |
||||
| 410 | 26873884 |
US |
86 | 2 |
Nasopharyngitis, Fatigue, |
||||
DUPILUMAB, |
||||
| 411 | 26873901 |
US |
2 | |
Nasopharyngitis, Muscular weakness, |
||||
FOSTAMATINIB, |
||||
| 412 | 26873961 |
US |
15 | 1 |
Nasopharyngitis, Cough, Nasal congestion, |
||||
DUPILUMAB, |
||||
| 413 | 26873975 |
US |
1 | |
Nasopharyngitis, Nasal congestion, |
||||
DUPILUMAB, EPINEPHRINE, |
||||
| 414 | 26873976 |
US |
72 | 2 |
COVID-19 pneumonia, Pneumonia, Seasonal allergy, Nasopharyngitis, Respiratory tract congestion, Headache, |
||||
TREPROSTINIL, TREPROSTINIL, AMBRISENTAN, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TADALAFIL, ERGOCALCIFEROL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DICYCLOMINE HYDROCHLORIDE, INSULIN GLARGINE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BACITRACIN, NEOMYCIN, POLYMYXIN B, PRAMOXINE HCL, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HYDROCHLORIDE, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE, BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND PRAMOXINE HYDROCHLORIDE, IRON, CLOPIDOGREL, CLOPIDOGREL BISULFATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MAGNESIUM, LORATADINE, LORATADINE TABLET, DIPHENHYDRAMINE HYDROCHLORIDE, INSULIN LISPRO, GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, OXYGEN, 0XYGEN, MONTELUKAST SODIUM, MONTELUKAST, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, VITAMIN C, AMITRIPTYLINE HYDROCHLORIDE, CYCLOBENZAPRINE, CETIRIZINE HYDROCHLORIDE, |
||||
| 415 | 26874222 |
US |
2 | |
Nasopharyngitis, Platelet count decreased, Product dose omission issue, Diarrhoea, |
||||
FOSTAMATINIB, |
||||
| 416 | 26874293 |
US |
2 | |
Nasopharyngitis, Platelet count decreased, |
||||
FOSTAMATINIB, |
||||
| 417 | 26874331 |
US |
72 | 1 |
Nasal congestion, Nasopharyngitis, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 418 | 26874371 |
US |
2 | |
Nasopharyngitis, Drug ineffective, Diarrhoea, |
||||
FOSTAMATINIB, |
||||
| 419 | 26874396 |
US |
2 | |
Nasopharyngitis, Influenza, |
||||
FOSTAMATINIB, |
||||
| 420 | 26874512 |
US |
2 | |
Eczema, Neutrophil count increased, Nasopharyngitis, Headache, Muscle spasms, Nasal congestion, Neutropenia, Nausea, Dizziness, Hepatic function abnormal, Aspartate aminotransferase increased, Diarrhoea, Neutrophil count decreased, |
||||
FOSTAMATINIB, FOSTAMATINIB, FOSTAMATINIB, FOSTAMATINIB, FOSTAMATINIB, |
||||
| 421 | 26874642 |
US |
2 | |
Nasopharyngitis, Headache, Diarrhoea, |
||||
FOSTAMATINIB, |
||||
| 422 | 26874674 |
US |
63 | 2 |
Platelet count decreased, Dyspepsia, Nasopharyngitis, Head discomfort, Chest discomfort, Cough, |
||||
FOSTAMATINIB, |
||||
| 423 | 26874675 |
US |
58 | 2 |
Nasopharyngitis, Product prescribing issue, Diarrhoea, |
||||
FOSTAMATINIB, FOSTAMATINIB, |
||||
| 424 | 26874898 |
US |
76 | 2 |
Nasopharyngitis, Oropharyngeal pain, |
||||
FOSTAMATINIB, AMLODIPINE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, AVATROMBOPAG MALEATE, ROMIPLOSTIM, |
||||
| 425 | 26875052 |
US |
46 | 2 |
Nasopharyngitis, Dyspnoea, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 426 | 26875056 |
US |
2 | |
Nasopharyngitis, |
||||
DUPILUMAB, DUPILUMAB, PITOLISANT HYDROCHLORIDE, |
||||
| 427 | 26867986 |
US |
||
Nasopharyngitis, Cough, |
||||
| 428 | 26868230 |
US |
2 | |
Dyspnoea, Nasopharyngitis, |
||||
TREPROSTINIL, MACITENTAN, SOTATERCEPT-CSRK, |
||||
| 429 | 26868312 |
CA |
||
Spinal disorder, Nasopharyngitis, Off label use, Cerebral disorder, Deafness, Product ineffective for unapproved use, Lack of injection site rotation, Tinnitus, |
||||
METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 430 | 26868318 |
GB |
76 | 2 |
Cataract operation, Nasopharyngitis, Urinary tract infection, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 431 | 26868652 |
US |
83 | 2 |
Nasopharyngitis, Cough, Myalgia, Fatigue, Asthenia, Dizziness, Confusional state, Fall, Adverse event, Drug ineffective, |
||||
| 432 | 26868752 |
US |
80 | 2 |
Respiratory tract congestion, Back pain, Rash, Product dose omission issue, Nasopharyngitis, |
||||
PEMBROLIZUMAB, ZANUBRUTINIB, ZANUBRUTINIB, ZANUBRUTINIB, ZANUBRUTINIB, |
||||
| 433 | 26868781 |
US |
56 | 2 |
Nasopharyngitis, |
||||
| 434 | 26868825 |
US |
70 | 1 |
Nasopharyngitis, |
||||
| 435 | 26868906 |
US |
51 | |
Chromaturia, Illness, Nasopharyngitis, Drug intolerance, Exercise tolerance decreased, Oropharyngeal discomfort, Diarrhoea, Cough, Cough, Oropharyngeal pain, Throat irritation, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, NINTEDANIB, ALBUTEROL SULFATE, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, OXYGEN, 0XYGEN, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, NINTEDANIB, |
||||
| 436 | 26868955 |
US |
74 | |
Dry throat, Nasopharyngitis, Nasal congestion, Abdominal discomfort, Sunburn, Diarrhoea, Dizziness, |
||||
TREPROSTINIL, TREPROSTINIL, PIRFENIDONE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FLECAINIDE ACETATE TABLET, FLECAINIDE ACETATE, ALENDRONATE SODIUM, PROPRANOLOL HYDROCHLORIDE, OXYGEN, 0XYGEN, AMLODIPINE BESYLATE, |
||||
| 437 | 26869015 |
US |
36 | 2 |
Nasopharyngitis, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 438 | 26869261 |
JP |
1 | |
Cytomegalovirus oesophagitis, Weight increased, Sinusitis, Dyslipidaemia, Rash, Sleep apnoea syndrome, Cough, Nasopharyngitis, |
||||
ATOVAQUONE, ATOVAQUONE ORAL SUSPENSION, ATOVAQUONE, ATOVAQUONE ORAL SUSPENSION, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, LANSOPRAZOLE, FLUCONAZOLE, LEMBOREXANT, DEXTROMETHORPHAN HYDROBROMIDE, RAMELTEON, HEPARIN SODIUM, PETROLATUM, WHITE PETROLATUM, ISHANCARE HEMORRHOID CREAM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, EPINASTINE HYDROCHLORIDE, ALBUTEROL SULFATE, ALBUTEROL, MEPERIDINE HYDROCHLORIDE, DEXTROSE MONOHYDRATE, DEXTROSE, AMOXICILLIN AND CLAVULANATE POTASSIUM, AMOXICILLIN, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, |
||||
| 439 | 26869527 |
CA |
66 | 2 |
Autoimmune disorder, Diverticulitis, Diarrhoea, Diverticulum intestinal haemorrhagic, Fungal infection, Illness, Inflammatory pain, Myalgia, Nasopharyngitis, Oesophageal spasm, Oropharyngeal pain, Pneumonia, Skin hypertrophy, Urinary tract infection, Inappropriate schedule of product administration, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, CYCLOSPORINE, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 440 | 26869542 |
CO |
2 | |
Pneumonia, Mobility decreased, Nasopharyngitis, |
||||
DENOSUMAB, |
||||
| 441 | 26869832 |
US |
75 | 2 |
Nasopharyngitis, Drug ineffective, |
||||
VIBEGRON, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ATENOLOL, FUROSEMIDE, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, LEFLUNOMIDE, AMLODIPINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 442 | 26869846 |
GB |
29 | |
Crohn^s disease, Influenza like illness, Malaise, Injection site erythema, Injection site pain, Injection site reaction, Injection site mass, Nausea, Headache, Nasopharyngitis, Intentional dose omission, Therapy interrupted, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, ADALIMUMAB-AATY, ADALIMUMAB-AATY, AZATHIOPRINE, BUDESONIDE, |
||||
| 443 | 26869925 |
US |
72 | 2 |
Neuropathy peripheral, Cough, Muscular weakness, Memory impairment, Dysphagia, Fatigue, Myalgia, Diarrhoea, Nail disorder, Dry mouth, Nasopharyngitis, Skin fissures, Dry skin, |
||||
OSIMERTINIB, FOLIC ACID, GABAPENTIN, PANTOPRAZOLE SODIUM, SOLIFENACIN SUCCIATE, SOLIFENACIN SUCCINATE, |
||||
| 444 | 26869927 |
US |
||
Nasopharyngitis, |
||||
TREPROSTINIL, |
||||
| 445 | 26869979 |
US |
||
Nasopharyngitis, Cough, |
||||
TREPROSTINIL, |
||||
| 446 | 26870507 |
US |
78 | |
Foot fracture, Nasopharyngitis, Cough, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, FUROSEMIDE, FAMOTIDINE, ROSUVASTATIN CALCIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, LEVALBUTEROL HYDROCHLORIDE, ALENDRONATE SODIUM, SERTRALINE HYDROCHLORIDE, OXYGEN, 0XYGEN, ERGOCALCIFEROL, FLECAINIDE ACETATE TABLET, FLECAINIDE ACETATE, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, IPRATROPIUM BROMIDE, |
||||
| 447 | 26870509 |
US |
76 | |
Fatigue, Product dose omission issue, Lethargy, Pruritus, Back pain, Secretion discharge, Nasopharyngitis, Urinary incontinence, Cough, Diarrhoea, Throat irritation, Oropharyngeal pain, Adverse drug reaction, Drug intolerance, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, |
||||
| 448 | 26870518 |
US |
75 | |
Nasopharyngitis, Malaise, Seasonal allergy, Cough, Diarrhoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, CALCIUM CARBONATE, ANTACID, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, FOLIC ACID, FLUTICASONE PROPIONATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FUROSEMIDE, |
||||
| 449 | 26870534 |
US |
62 | |
Asthenia, Nasopharyngitis, Product dose omission issue, Illness, Alopecia, Sinus disorder, Fatigue, Headache, Hypotension, Hypersensitivity, Diarrhoea, Epistaxis, |
||||
TREPROSTINIL, TREPROSTINIL, METHOCARBAMOL, METHOCARBAMOL TABLETS, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE, THYROID, PORCINE, FUROSEMIDE, SILDENAFIL CITRATE, SILDENAFIL, HYDROXYCHLOROQUINE SULFATE, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MACITENTAN, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, OXYGEN, 0XYGEN, |
||||
| 450 | 26870538 |
US |
75 | |
Nasopharyngitis, Eye infection, Cough, |
||||
TREPROSTINIL, TREPROSTINIL, MELOXICAM, FUROSEMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ESCITALOPRAM OXALATE, ESCITALOPRAM, ROSUVASTATIN CALCIUM, EMPAGLIFLOZIN, ERGOCALCIFEROL, GABAPENTIN, TADALAFIL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, MIDODRINE HYDROCHLORIDE, OXYGEN, 0XYGEN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SOTATERCEPT-CSRK, |
||||
| 451 | 26870561 |
US |
61 | |
Pyrexia, Nasopharyngitis, Chills, Headache, |
||||
TREPROSTINIL, |
||||
| 452 | 26870656 |
CA |
||
Abdominal mass, Blood calcium decreased, Blood magnesium decreased, Blood pressure abnormal, Chondrocalcinosis, Crohn^s disease, Diabetes mellitus, Dry eye, Hypoaesthesia, Intestinal obstruction, Paraesthesia, Incision site haemorrhage, Peripheral swelling, Drug eruption, Constipation, Diverticulitis, Furuncle, COVID-19, Bacteraemia, Abscess, Nasopharyngitis, Urinary tract infection bacterial, Therapeutic reaction time decreased, |
||||
BUDESONIDE, BUDESONIDE, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, CEFIXIME, CEFTRIAXONE, CEFTRIAXONE SODIUM, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, PREDNISONE, |
||||
| 453 | 26871223 |
78 | ||
Nasopharyngitis, Off label use, |
||||
RUXOLITINIB, LOVASTATIN, |
||||
| 454 | 26871376 |
|||
Nasopharyngitis, Pyrexia, Fatigue, |
||||
| 455 | 26871507 |
2 | ||
Nasopharyngitis, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 456 | 26871856 |
US |
||
Eructation, Sinus congestion, Nasopharyngitis, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, |
||||
| 457 | 26872016 |
CA |
43 | 2 |
Wound, Abdominal discomfort, Abdominal pain upper, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Autoimmune disorder, Back injury, Blister, Breast cancer stage II, Breast cancer stage III, Bursitis, C-reactive protein increased, Contraindicated product administered, Dislocation of vertebra, Exostosis, Feeling hot, Frequent bowel movements, Inflammation, Live birth, Lupus vulgaris, Maternal exposure before pregnancy, Maternal exposure during pregnancy, Migraine, Musculoskeletal pain, Osteoporosis, Pain, Pericarditis, Peripheral swelling, Peripheral venous disease, Product quality issue, Psoriatic arthropathy, Pyrexia, Rash, Red blood cell sedimentation rate increased, Synovitis, Taste disorder, Vomiting, Weight increased, Blepharospasm, Blood cholesterol increased, Decreased appetite, Depression, Diarrhoea, Dizziness, Dry mouth, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Headache, Hepatic enzyme increased, Hypocholesterolaemia, Impaired healing, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Memory impairment, Muscle injury, Muscle spasms, Nail disorder, Nasopharyngitis, Obesity, Osteoarthritis, Paraesthesia, Pemphigus, Rheumatoid arthritis, Stomatitis, Swelling, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Wheezing, Wound infection, Night sweats, No adverse event, Off label use, Exposure during pregnancy, Product use in unapproved indication, |
||||
HYDROMORPHONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, TRAMADOL HYDROCHLORIDE, ERENUMAB-AOOE, ALENDRONATE SODIUM, SULFASALAZINE, BETAMETHASONE DIPROPIONATE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE HYDROCHLORIDE, CANDESARTAN, CANDESARTAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SECUKINUMAB, SECUKINUMAB, CYCLOBENZAPRINE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE HYDROCHLORIDE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PHENYLEPHRINE HYDROCHLORIDE, PHOSPHORUS, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PYRIDOXINE HYDROCHLORIDE, RAMIPRIL, RANITIDINE HYDROCHLORIDE, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, APREMILAST, APREMILAST, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, CELECOXIB, CELECOXIB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB CITRATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TRETINOIN, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, VITAMIN C, ERGOCALCIFEROL, TOFACITINIB, TOFACITINIB, HYDROXYCHLOROQUINE SULFATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALBUTEROL SULFATE, FISH OIL, RISEDRONATE SODIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, LISINOPRIL, LORAZEPAM, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 458 | 26872345 |
US |
2 | |
Rash, Drug ineffective, Gastrointestinal disorder, Pain, Nasopharyngitis, |
||||
RAVULIZUMAB, |
||||
| 459 | 26872632 |
|||
Nasopharyngitis, Gastroenteritis, Eructation, Gastrointestinal disorder, Muscle spasms, Vomiting, Nausea, |
||||
RUXOLITINIB, BELUMOSUDIL, |
||||
| 460 | 26872833 |
US |
34 | 1 |
Product dose omission issue, Nasopharyngitis, Back disorder, |
||||
MITAPIVAT, |
||||
| 461 | 26862643 |
US |
56 | 1 |
Clostridium difficile infection, Left ventricular hypertrophy, Seizure, Mitral valve calcification, Renal impairment, Food refusal, Product prescribing issue, Fatigue, Pain, Therapy interrupted, Somnolence, Dehydration, Chest pain, Decreased appetite, Influenza, Blood potassium decreased, Cough, Malaise, Nasopharyngitis, Urinary tract infection, White blood cell count increased, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, |
||||
| 462 | 26862874 |
KR |
79 | |
Neutropenia, Neuropathy peripheral, Hiccups, Nasopharyngitis, Diarrhoea, |
||||
BEVACIZUMAB-ADCD, BEVACIZUMAB-ADCD, BEVACIZUMAB-ADCD, BEVACIZUMAB-ADCD, BEVACIZUMAB-ADCD, BEVACIZUMAB-ADCD, BEVACIZUMAB-ADCD, BEVACIZUMAB-ADCD, BEVACIZUMAB-ADCD, BEVACIZUMAB-ADCD, EMPAGLIFLOZIN, |
||||
| 463 | 26862933 |
CA |
62 | 2 |
Rheumatoid arthritis, Nasopharyngitis, Injection site pain, Arthralgia, Peripheral swelling, |
||||
ADALIMUMAB-RYVK, ADALIMUMAB-RYVK, ADALIMUMAB-RYVK, ADALIMUMAB-RYVK, |
||||
| 464 | 26862957 |
PA |
72 | 2 |
Metastases to lung, Pulmonary oedema, Pulmonary thrombosis, Cough, Gait disturbance, Joint swelling, Osteoporosis, Cholelithiasis, Hypersensitivity, Nasopharyngitis, Headache, Pruritus, Scratch, Constipation, Vomiting, Discomfort, Movement disorder, Skin discolouration, Alopecia, Skin lesion, Lung disorder, Back pain, Condition aggravated, Malaise, Pleural disorder, Dyspepsia, Pallor, Cold sweat, Agitation, Fatigue, Respiratory rate decreased, Pain in extremity, Peripheral swelling, Pulmonary mass, Lethargy, Somnolence, Pyrexia, Chills, Rhinorrhoea, Productive cough, |
||||
FULVESTRANT, RIBOCICLIB, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, IRBESARTAN, |
||||
| 465 | 26863036 |
PA |
2 | |
Metastases to lung, Metastases to liver, Metastases to spine, Choking sensation, Feeling hot, Food allergy, Pruritus, Rash erythematous, Nasopharyngitis, Cough, Erythema, Sensitive skin, Skin exfoliation, Skin abrasion, Pain in extremity, Hypokinesia, Pleural mass, Hypersensitivity, Laziness, Feeling abnormal, Alopecia, Dry skin, Skin atrophy, Dizziness, Arthralgia, Somnolence, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, RIBOCICLIB, CALCIUM, DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, FOLIC ACID, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 466 | 26863420 |
CA |
74 | 2 |
Pneumothorax, Nausea, Rheumatoid arthritis, Dyspnoea exertional, Diarrhoea, Asthenia, Nasopharyngitis, Dyspnoea, Asthenia, |
||||
NINTEDANIB, NINTEDANIB, |
||||
| 467 | 26863809 |
CA |
59 | 2 |
Oedema peripheral, Bronchitis, Nasopharyngitis, Fibromyalgia, Malaise, Fatigue, Rheumatoid arthritis, Hypersensitivity, Musculoskeletal stiffness, Duodenal ulcer perforation, Type 2 diabetes mellitus, Adverse event, Therapeutic product effect decreased, Rheumatic fever, Lupus vulgaris, Joint swelling, Hypertension, Alopecia, Decreased appetite, Pemphigus, Therapeutic product effect incomplete, Helicobacter infection, Discomfort, Anti-cyclic citrullinated peptide antibody positive, Retinitis, Hypercholesterolaemia, Abdominal discomfort, Blood cholesterol increased, Hypoaesthesia, Contraindicated product administered, |
||||
ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE HYDROCHLORIDE, OXYCODONE, RAMIPRIL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TELMISARTAN, LANSOPRAZOLE, LANSOPRAZOLE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ASCORBIC ACID, PHENYLEPHRINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SECUKINUMAB, SECUKINUMAB, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DESOXIMETASONE, ERGOCALCIFEROL, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, BUPROPION, ACETAMINOPHEN AND CODEINE, LISINOPRIL, CAFFEINE CITRATE, HYDROMORPHONE HYDROCHLORIDE, QUETIAPINE FUMARATE, QUETIAPINE, LORAZEPAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, BUPROPION HYDROCHLORIDE, SULFASALAZINE, |
||||
| 468 | 26864115 |
US |
||
Hyperhidrosis, Nasopharyngitis, |
||||
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, |
||||
| 469 | 26864150 |
US |
14 | 1 |
Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 470 | 26864365 |
CA |
19 | 2 |
Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Autoimmune disorder, Blister, C-reactive protein, Condition aggravated, Confusional state, Contusion, Deep vein thrombosis postoperative, Discomfort, Drug intolerance, Duodenal ulcer perforation, Dyspnoea, Fatigue, Folliculitis, Gastrointestinal disorder, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Hypertension, Ill-defined disorder, Infection, Infusion related reaction, Injury, Joint swelling, Lip dry, Liver disorder, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Malaise, Mobility decreased, Musculoskeletal stiffness, Nasopharyngitis, Night sweats, Oedema, Osteoarthritis, Pain, Pemphigus, Pericarditis, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Sciatica, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swollen joint count increased, Systemic lupus erythematosus, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Weight increased, Wound, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ACETAMINOPHEN AND CODEINE, LORAZEPAM, CAFFEINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PIROXICAM, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LISINOPRIL, MAGNESIUM, MELOXICAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RISEDRONATE SODIUM, SULFASALAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN C, ERGOCALCIFEROL, |
||||
| 471 | 26864427 |
US |
77 | 2 |
Nasopharyngitis, |
||||
LENALIDOMIDE, |
||||
| 472 | 26864779 |
CA |
39 | |
Nausea, Crohn^s disease, Frequent bowel movements, Malaise, Off label use, Pneumonia viral, Abdominal pain, Faeces soft, Fatigue, Back pain, Mucous stools, Nasopharyngitis, Arthralgia, Diarrhoea haemorrhagic, Haematochezia, Social problem, Diarrhoea, Impaired work ability, Therapeutic reaction time decreased, Vomiting, |
||||
METHOTREXATE, METHOTREXATE SODIUM, VEDOLIZUMAB, |
||||
| 473 | 26865225 |
CA |
2 | |
Muscular weakness, Nasopharyngitis, Prescribed overdose, Pulmonary fibrosis, Synovitis, Lupus vulgaris, Musculoskeletal stiffness, Osteoarthritis, Red blood cell sedimentation rate increased, Visual impairment, Joint swelling, Peripheral swelling, Prescribed underdose, Rash, Rheumatoid factor positive, Seronegative arthritis, Swollen joint count increased, Wound infection, Irritable bowel syndrome, Joint dislocation, Liver injury, Pemphigus, Pericarditis, Pruritus, Systemic lupus erythematosus, Weight decreased, Wound, Joint range of motion decreased, Joint stiffness, Laryngitis, Lower limb fracture, Memory impairment, Pain, Psoriasis, Psoriatic arthropathy, Pyrexia, Retinitis, Rheumatic fever, Lupus-like syndrome, Pneumonia, Road traffic accident, Tachycardia, Urticaria, Vomiting, Intentional product use issue, Mobility decreased, Nausea, Oedema peripheral, Pain in extremity, Sciatica, Upper respiratory tract infection, Wheezing, Liver function test increased, Muscle injury, Oedema, Osteoporosis, Rheumatoid arthritis, Sinusitis, Type 2 diabetes mellitus, Weight increased, |
||||
HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, QUETIAPINE FUMARATE, QUETIAPINE, PREGABALIN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, AZATHIOPRINE, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CLONIDINE HYDROCHLORIDE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, INFLIXIMAB, INFLIXIMAB, MESALAMINE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, SALICYLIC ACID, MEDICATED CORN REMOVERS, LIQUID WART REMOVER, ULTRA THIN CORN REMOVERS, EXTRA THICK CALLUS REMOVERS, MEDICATED WART REMOVERS, CORN AND CALLUS REMOVER KIT, WART REMOVERS, WART REMOVER LIQUID, MEDICATED CALLUS REMOVERS, WART REMOVER GEL, MEDICATED PLANTAR WART REMOVER, MEDICATED CALLUS REMOVERS EXTRA THICK, MEDICATED CORN REMOVER, WART REMOVER, CLEAR MEDICATED CORN REMOVERS, CORN REMOVERS, BOSYE BENEFITING HAIR LOTION, LIQUID CORN AND CALLUS REMOVER, WART REMOVER MEDICATED DISCS, WART REMOVER GEL TUBE, SALICYLIC ACID 12%, CALLUS REMOVERS, ASTRINGENT, CORN AND CALLUS REMOVER, GEL CORN REMOVER, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, APREMILAST, APREMILAST, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREGABALIN, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TOFACITINIB CITRATE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRICLOSAN, USTEKINUMAB, ERGOCALCIFEROL, |
||||
| 474 | 26865343 |
US |
2 | |
Vision blurred, Nasopharyngitis, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 475 | 26865781 |
CA |
1 | |
Pneumonia, Nasopharyngitis, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 476 | 26866236 |
US |
2 | |
Nasopharyngitis, Drug ineffective, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ANASTROZOLE, ANASTROZOLE TABLETS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, CHOLESTYRAMINE, FLUTICASONE PROPIONATE, ISOSORBIDE MONONITRATE, LISINOPRIL, LORATADINE, LORATADINE ORAL, MAGNESIUM OXIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MONTELUKAST SODIUM, MONTELUKAST, NITROGLYCERIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, CALCIUM CARBONATE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, FAMOTITINE, SERTRALINE HYDROCHLORIDE, VITAMIN C, ERGOCALCIFEROL, VITAMIN E, BUPROPION HYDROCHLORIDE, ZOLEDRONIC ACID, |
||||
| 477 | 26866459 |
BR |
62 | 2 |
Pneumonia, Nasopharyngitis, Inappropriate schedule of product administration, |
||||
BENRALIZUMAB, BENRALIZUMAB, BECLOMETHASONE DIPROPIONATE, BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRROLATE, CLARITHROMYCIN, |
||||
| 478 | 26866639 |
US |
||
Illness, Thinking abnormal, Product storage error, Nasopharyngitis, Off label use, Off label use, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 479 | 26866654 |
2 | ||
Atrial flutter, Renal disorder, Liver disorder, Nasopharyngitis, |
||||
RIBOCICLIB, |
||||
| 480 | 26866754 |
US |
2 | |
Ostomy bag placement, Pulmonary embolism, Intestinal perforation, Injection site rash, Post procedural infection, Multiple allergies, Colonic abscess, Fistula, Peritonitis, Crohn^s disease, Nasopharyngitis, Influenza, |
||||
ADALIMUMAB, |
||||
| 481 | 26866882 |
KR |
64 | 2 |
Abscess, Nocardiosis, Brain abscess, Seizure, Seizure, Seizure, Nasopharyngitis, Productive cough, Cough, Urinary tract infection, |
||||
AVACOPAN, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, GATIFLOXACIN, TENOFOVIR ALAFENAMIDE, TRANEXAMIC ACID, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, CEFTAZIDIME, ERTAPENEM SODIUM, INSULIN ASPART INJECTION, INSULIN ASPART, INSULIN LISPRO, INSULIN DEGLUDEC, CARVEDILOL, LINAGLIPTIN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, LEVETIRACETAM, LEVETIRACETAM, |
||||
| 482 | 26867176 |
US |
71 | |
Nasopharyngitis, Fatigue, Headache, Cough, Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, RIOCIGUAT, MACITENTAN, FUROSEMIDE, ERGOCALCIFEROL, VITAMIN C, TIOTROPIUM BROMIDE, ERGOCALCIFEROL, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, OXYGEN, 0XYGEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 483 | 26867182 |
US |
67 | |
Nephrolithiasis, Urinary tract infection, Fatigue, Pain, Injection site pain, Dysgeusia, Nasopharyngitis, Pyrexia, Unevaluable event, Product dose omission issue, Inappropriate schedule of product administration, Injection site bruising, Anger, Injection site induration, Injection site discolouration, Cough, Oropharyngeal pain, Dyspnoea, Throat irritation, Diarrhoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, VITAMIN C, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, PANTOPRAZOLE SODIUM, SERTRALINE HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, ROSUVASTATIN CALCIUM, LOSARTAN POTASSIUM, LOSARTAN, DIAZEPAM, ERGOCALCIFEROL, AMITRIPTYLINE HYDROCHLORIDE, EPLERENONE, GABAPENTIN, DIGOXIN, GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE, |
||||
| 484 | 26867210 |
US |
60 | |
Vascular injury, Pruritus, Nasopharyngitis, Haemoptysis, Blood pressure fluctuation, Epistaxis, Cough, Throat irritation, Headache, Nausea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, RIVAROXABAN, ALBUTEROL SULFATE, OXYGEN, 0XYGEN, CITALOPRAM, CITALOPRAM HYDROBROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 485 | 26867542 |
CA |
43 | 2 |
Contraindicated product administered, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Infusion site reaction, Injury, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Lung disorder, Memory impairment, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Nausea, Obesity, Off label use, |
||||
HYDROMORPHONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, BUPRENORPHINE, BUPRENORPHINE, LEFLUNOMIDE, LEFLUNOMIDE, AZATHIOPRINE, BETAMETHASONE DIPROPIONATE, BOTULINUM TOXIN TYPE A, CANDESARTAN, CANDESARTAN, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, CYCLOBENZAPRINE, DICLOFENAC, DICLOFENAC SODIUM, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, FLUTICASONE PROPIONATE, ALENDRONATE SODIUM, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, MINOCYCLINE, NAPROXEN, NAPROXEN SODIUM, ABATACEPT, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, LEFLUNOMIDE, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
| 486 | 26867933 |
US |
31 | 1 |
Nasopharyngitis, Product dose omission issue, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 487 | 26857388 |
US |
34 | 2 |
Upper respiratory tract infection, Nasopharyngitis, Oral herpes, Injection site pain, Dry eye, |
||||
DUPILUMAB, |
||||
| 488 | 26857620 |
US |
1 | |
Nasopharyngitis, |
||||
SECUKINUMAB, |
||||
| 489 | 26857979 |
US |
80 | 2 |
Nasopharyngitis, Oropharyngeal pain, |
||||
LENALIDOMIDE, |
||||
| 490 | 26857981 |
GB |
61 | |
Gout, Headache, Infection, Skin infection, Sinusitis, Nerve compression, Tooth fracture, Anxiety, Oropharyngeal pain, Injection site warmth, Depression, Nasopharyngitis, Injection site mass, Injection site cellulitis, Injection site erythema, Off label use, Intentional dose omission, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 491 | 26858112 |
US |
18 | 2 |
Nasopharyngitis, Tremor, Nausea, Myalgia, Back pain, Arthralgia, Headache, Anxiety, |
||||
TEPLIZUMAB-MZWV, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 492 | 26858279 |
US |
73 | 2 |
Nasopharyngitis, |
||||
POMALIDOMIDE, |
||||
| 493 | 26858397 |
US |
2 | |
Nasopharyngitis, |
||||
| 494 | 26858430 |
CA |
39 | |
Hospitalisation, Harvey-Bradshaw index increased, Malaise, Poor quality sleep, Vomiting, Personality disorder, Cough, Infusion site paraesthesia, Abdominal pain, Drug specific antibody present, Influenza, Cellulitis, Pruritus, Paraesthesia, Fatigue, Infusion related reaction, Nasopharyngitis, Treatment noncompliance, Product dose omission issue, Off label use, Inappropriate schedule of product administration, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB, DIPHENHYDRAMINE HYDROCHLORIDE, HYDROCORTISONE SODIUM SUCCINATE, |
||||
| 495 | 26858613 |
US |
76 | 2 |
Herpes zoster, Nasopharyngitis, Nasopharyngitis, Immune system disorder, Herpes virus infection, |
||||
RISANKIZUMAB-RZAA, |
||||
| 496 | 26858754 |
US |
1 | |
Hypoaesthesia, Nasopharyngitis, Paraesthesia, |
||||
NUSINERSEN, |
||||
| 497 | 26858781 |
US |
70 | |
Nasopharyngitis, |
||||
| 498 | 26859083 |
CA |
65 | 2 |
Vomiting, Adjustment disorder, Affect lability, Angina pectoris, Anxiety, Aphasia, Arterial occlusive disease, Arthritis, Asthenia, Blood pressure increased, Carotid artery thrombosis, Cataract, Cerebrovascular accident, Chest discomfort, Confusional state, Coordination abnormal, Cough, Cystitis, Dysarthria, Dysphagia, Eating disorder, Fall, Fatigue, Gangrene, Gastrointestinal disorder, Headache, Hemiparesis, Hemiplegia, Influenza, Influenza like illness, Malaise, Motor dysfunction, Muscle spasticity, Muscular weakness, Nasopharyngitis, Nausea, Neurologic neglect syndrome, Pain, Palpitations, Personality disorder, Pneumonia, Psoriasis, Pyrexia, Respiratory tract congestion, Rheumatoid arthritis, Rhinorrhoea, Sensory loss, Sinus congestion, Sinus disorder, Sinusitis, Skin exfoliation, Skin haemorrhage, Sneezing, |
||||
AMLODIPINE, AMLODIPINE, CANDESARTAN CILEXETIL, IRBESARTAN, LISINOPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, RAMIPRIL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, BISOPROLOL FUMARATE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ERGOCALCIFEROL, DIMENHYDRINATE, SITAGLIPTIN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ATORVASTATIN CALCIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE, MORPHINE SULFATE, NAPROXEN, NAPROXEN SODIUM, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PREDNISOLONE SODIUM PHOSPHATE, PREDNISONE, PROCHLORPERAZINE, RITUXIMAB, IRBESARTAN, LEVOTHYROXINE SODIUM, LISINOPRIL, ZOLPIDEM TARTRATE, ACITRETIN, IRBESARTAN, COAL TAR, CYANOCOBALAMIN, DULOXETINE HYDROCHLORIDE, EZETIMIBE, INSULIN LISPRO, HYDROCHLOROTHIAZIDE, INSULIN GLARGINE, PREGABALIN, METHYLPREDNISOLONE ACETATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ROSUVASTATIN CALCIUM, USTEKINUMAB, TELMISARTAN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 499 | 26859335 |
CA |
17 | |
Off label use, Dysmenorrhoea, Nasopharyngitis, Rheumatoid arthritis, Juvenile idiopathic arthritis, Diarrhoea, Abdominal pain upper, Gastric ulcer, Fatigue, Decreased appetite, Haematochezia, |
||||
NAPROXEN, NAPROXEN SODIUM, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CELECOXIB, |
||||
| 500 | 26859473 |
US |
2 | |
Myocardial infarction, Cerebrovascular accident, Carotid artery occlusion, Nasopharyngitis, |
||||
EVOLOCUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30